Gregory D Perry's Net Worth

$930 Thousand

Estimate Recalculated Jul 3, 2024 03:22PM EST

Who is Gregory D Perry?

Gregory D Perry does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNOGEN INC, Merus N.V., Finch Therapeutics Group, Inc., Eleven Biotherapeutics, Inc., Kala Pharmaceuticals, Inc., INVIVO THERAPEUTICS HOLDINGS CORP., NOVELION THERAPEUTICS INC., Ocata Therapeutics, Inc., Aegerion Pharmaceuticals, Inc., and TRANSKARYOTIC THERAPIES INC.

SEC CIK

Gregory D Perry's CIK is 0001236371

Past Insider Trading and Trends

2011 was Gregory D Perry's most active year for acquiring shares with 10 total transactions. Gregory D Perry's most active month to acquire stocks was the month of May. 2011 was Gregory D Perry's most active year for disposing of shares, totalling 12 transactions. Gregory D Perry's most active month to dispose stocks was the month of June. 2013 saw Gregory D Perry paying a total of $2,171,415.84 for 1,150,711 shares, this is the most they've acquired in one year. In 2005 Gregory D Perry cashed out on 146,459 shares for a total of $3,625,938.42, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOGEN INC (IMGN) Snapshot price: $29.595

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$11.07
-$247,476.15
0
Scheduled
Sep 10
Form 4
—
0
—
—
0
Jul 16
Form 4
—
0
—
—
0
Jul 20
Form 4
—
0
$8.45
-$68,863.91
0
Scheduled
Nov 15
Form 4
—
0
$8.86
-$75,646.97
0
Scheduled
Oct 17
Form 4
—
0
$7.66
-$55,664.44
0
Scheduled
Sep 26
Form 4
—
0
$7.69
-$56,122.75
0
Scheduled
Aug 15
Form 4
—
0
—
—
0
Jul 22
Form 4
—
0
$9.72
-$90,021.40
0
Scheduled
Jul 15
Form 4
—
0
$8.20
-$64,572.42
0
Scheduled
Jun 29
Form 4
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Jul 23
Form 4
—
0
—
—
0
Jul 24
Form 4
—
0
—
—
0
Jan 9
Form 3
—
0
—
—
0
No matching records found

Merus N.V. (MRUS) Snapshot price: $37.695

Chief Financial Officer & PFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 7
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Jun 30
Form 3
—
0
—
—
0
No matching records found

Finch Therapeutics Group, Inc. (FNCH) Snapshot price: $2.77

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Mar 18
Form 3
—
0
—
—
0
No matching records found

Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $2

Chief Financial and Business

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 26
Form 3
—
0
—
—
0
No matching records found

KALA BIO, Inc. (KALA) Snapshot price: $7.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+14.75%
1.4K
—
—
10.89K
Jun 11
Form 4
+274.07%
6.96K
—
—
9.49K
Jun 22
Form 4
+217.25%
1.74K
—
—
2.54K
May 31
Form 4
—
0
—
—
0
Jun 16
Form 4
+100.00%
20K
—
—
40K
Jun 17
Form 4
∞
20K
—
—
20K
Jun 25
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Feb 28
Form 3
—
0
—
—
0
No matching records found